# Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

> **NCT06975085** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 781 (actual)

## Conditions studied

- Breast Cancer Female

## Interventions

- **BEHAVIORAL:** Presentation of a personal breast cancer risk estimate

## Key facts

- **NCT ID:** NCT06975085
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-16
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 781 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06975085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06975085, "Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06975085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*